Skip to content

Clinical trials

Myotonic Dystrophy trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myotonic Dystrophy Country / region: United Kingdom Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20131
20141
20151
20161
20191
20201
20211
20221
20232
20245
20255
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Recruiting8
Enrolling by invitation4
Active, not recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Avidity Biosciences, Inc.3
Lupin Ltd.3
AMO Pharma Limited2
Dyne Therapeutics2
PepGen Inc2
Vertex Pharmaceuticals Incorporated2
ARTHEx Biotech S.L.1
Newcastle University1
Newcastle-upon-Tyne Hospitals NHS Trust1
Radboud University Medical Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myotonic Dystrophy22
Myotonic Disorders6
Muscular Dystrophies5
Myotonia5
Neuromuscular Diseases5
Genetic Diseases, Inborn4
Muscular Diseases4
Muscular Disorders, Atrophic4
Musculoskeletal Diseases4
Nervous System Diseases4

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.